Clinical trials
Breast Neoplasms trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
837 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 7 |
| 2002 | 8 |
| 2003 | 12 |
| 2004 | 19 |
| 2005 | 16 |
| 2006 | 22 |
| 2007 | 30 |
| 2008 | 22 |
| 2009 | 30 |
| 2010 | 19 |
| 2011 | 19 |
| 2012 | 43 |
| 2013 | 43 |
| 2014 | 38 |
| 2015 | 32 |
| 2016 | 34 |
| 2017 | 34 |
| 2018 | 30 |
| 2019 | 40 |
| 2020 | 54 |
| 2021 | 50 |
| 2022 | 42 |
| 2023 | 55 |
| 2024 | 49 |
| 2025 | 52 |
| 2026 | 23 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 448 |
| Recruiting | 118 |
| Active, not recruiting | 107 |
| Terminated | 87 |
| Unknown status | 57 |
| Not yet recruiting | 10 |
| Enrolling by invitation | 4 |
| Approved for marketing | 3 |
| Withdrawn | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 77 |
| Novartis Pharmaceuticals | 61 |
| AstraZeneca | 43 |
| Spanish Breast Cancer Research Group | 43 |
| Eli Lilly and Company | 34 |
| Pfizer | 30 |
| SOLTI Breast Cancer Research Group | 29 |
| MedSIR | 27 |
| Genentech, Inc. | 17 |
| GlaxoSmithKline | 14 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 837 |
| Neoplasm Metastasis | 78 |
| Neoplasms | 66 |
| Ovarian Neoplasms | 37 |
| Carcinoma, Non-Small-Cell Lung | 33 |
| Triple Negative Breast Neoplasms | 33 |
| Colorectal Neoplasms | 27 |
| Endometrial Neoplasms | 23 |
| Lung Neoplasms | 19 |
| Stomach Neoplasms | 19 |
Trials
Showing 76 to 100 of 837. Each trial links to its page on Pharma Observatory.
737 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.